Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
Klaudyna Fidyt(Polish Academy of Sciences), Małgorzata Firczuk(Medical University of Warsaw), Wojciech Młynarski(Medical University of Silesia), Angelika Muchowicz(Medical University of Warsaw), Julia Cyran(Medical University of Warsaw), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Krzysztof Domka(Medical University of Warsaw), Joanna Madzio(Medical University of Warsaw), Karolina Siudakowska(Medical University of Warsaw), Jakub Gołąb(Medical University of Warsaw), Agnieszka Graczyk‐Jarzynka(Medical University of Warsaw), Lukasz Komorowski(Medical University of Warsaw), Joe Harman(University of Oxford), Elżbieta Patkowska(Institute for Transfusion Medicine), Martyna Poprzeczko(Medical University of Warsaw), Nicholas T. Crump(Imperial College London), Agnieszka Góral(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Agata Pastorczak(Medical University of Lodz), Magdalena Winiarska(Medical University of Warsaw), Thomas A. Milne(University of Oxford)
Cited by 18
Related Papers
Photodynamic therapy of cancer: An update
|CA A Cancer Journal for Clinicians|2011|5.1k
<i>β</i>‐caryophyllene and <i>β</i>‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
|Cancer Medicine|2016|642
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
Myeloid Cell-Derived Arginase in Cancer Immune Response
|Frontiers in Immunology|2020|411